BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15308367)

  • 1. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
    Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
    J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis on two different measles immunization strategies].
    Wu H; Wang K; Zhang X; Jin S; Feng Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):121-3. PubMed ID: 11860771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign.
    Bernhardt GL; Cameron NA; Willems B; Boulle A; Coetzee D
    S Afr Med J; 2013 Jan; 103(3):181-6. PubMed ID: 23472696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of supplementary immunization for measles in India.
    Dabral M
    Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis.
    Driessen J; Olson ZD; Jamison DT; Verguet S
    Soc Sci Med; 2015 Aug; 139():115-22. PubMed ID: 26189009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C; Konde MK; Yaméogo A; Tiendrébéogo SR; Ouédraogo RT; Otten MW; Cairns KL; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Grabowsky M; Nobiya T; Selanikio J
    Trop Med Int Health; 2007 Jul; 12(7):815-22. PubMed ID: 17596247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Measles Initiative to control measles in Kenya.
    Bradsher CA; Stotts RC; Carter MA; Grabowsky M
    Public Health Nurs; 2007; 24(1):26-33. PubMed ID: 17214650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
    Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001).
    Cliff J; Simango A; Augusto O; Van Der Paal L; Biellik R
    J Infect Dis; 2003 May; 187 Suppl 1():S51-7. PubMed ID: 12721891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.